Patrick Ryan Potts Selected Research

Patrick Ryan Potts Research Topics

15	Neoplasms (Cancer) 11/2020 - 07/2007
9	Melanoma (Melanoma, Malignant) 11/2020 - 09/2010
5	Carcinogenesis 11/2020 - 09/2010
2	Neurodevelopmental Disorders 11/2020 - 09/2015
2	Testicular Neoplasms (Testicular Cancer) 01/2019 - 09/2010
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 01/2020
1	Starvation 01/2019
1	Schaaf-Yang syndrome 01/2017
1	Genomic Instability 01/2017
1	Chromosomal Instability (Chromosome Stability) 01/2017
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2017
1	Disease Progression 01/2016
1	Hypersensitivity (Allergy) 08/2005
1	Pheochromocytoma 10/2004

12	Proteins (Proteins, Gene)FDA Link 12/2021 - 02/2015
9	AntigensIBA 11/2020 - 09/2010
7	Ligases (Synthetase)IBA 10/2020 - 08/2005
6	UbiquitinIBA 10/2020 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 07/2012
2	Phosphotransferases (Kinase)IBA 01/2017 - 02/2015
1	snake venom protein C activatorIBA 12/2021
1	Messenger RNA (mRNA)IBA 01/2020
1	Cyclin D2IBA 01/2020
1	Sirtuin 1IBA 01/2020
1	3' Untranslated Regions (3' UTR)IBA 01/2020
1	NeuropeptidesIBA 01/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019
1	Melanoma-Specific AntigensIBA 01/2019
1	IronIBA 01/2018
1	SulfurIBA 01/2018
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2017
1	Tumor Biomarkers (Tumor Markers)IBA 01/2017
1	Exonucleases (3' 5' Exonuclease)IBA 01/2017
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2017
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2016
1	Telomere-Binding ProteinsIBA 07/2007
1	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2007
1	Cytochromes c (Cytochrome c)IBA 10/2004

2	Immunotherapy 11/2020 - 12/2015
2	Therapeutics 10/2020 - 01/2019